Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A for Peripheral TMD Pain Mechanisms
NCT05720065Phase 2Recruiting
- Sponsor
- Karolinska Institutet
- Start
- Nov 2023
- Primary completion
- Aug 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in temporomandibular disorders (TMD), sponsored by Karolinska Institutet. Started Nov 2023; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
temporomandibular disorders (TMD)
Beyond the preview
Go deeper on NCT05720065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05720065.